Hun J Lee
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hun J Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:27 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04047797 · Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaM.D. Anderson Cancer Center · terminated · Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma · principal investigator
- Ph1NCT02269085 · Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
- Ph2NCT02042950 · A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
- Ph1NCT01729104 · Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell LymphomaM.D. Anderson Cancer Center · terminated · Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 54 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:27 UTC. The ranking covers the 200 most relevant of 521 PubMed records, and a shared surname and initials can bring in a namesake. All 521 on PubMed
- 370 citationsRCR 21.4
- Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.Blood · 2019277 citationsRCR 9.0
- Multicenter Prospective Comparative Study of Robotic Versus Laparoscopic Gastrectomy for Gastric Adenocarcinoma.Ann Surg · 2016260 citationsRCR 12.4
- 234 citationsRCR 13.0
- Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system.Diabetes Care · 2011142 citationsRCR 5.9
- Effects of Probiotic NVP-1704 on Mental Health and Sleep in Healthy Adults: An 8-Week Randomized, Double-Blind, Placebo-Controlled Trial.Nutrients · 2021132 citationsRCR 10.3
- Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.Lancet Haematol · 2021131 citationsRCR 7.1
- What is the best reconstruction method after distal gastrectomy for gastric cancer?Surg Endosc · 2012114 citationsRCR 4.1
- 110 citationsRCR 15.9
- 107 citationsRCR 3.6